| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |